Offstream
news

Johnson & Johnson officially suspends production of its COVID-19 vaccine. It says production will likely resume later, and that millions of doses remain stocked for distribution per earlier agreements.
2022-02-9

The Medicines Control Authority of Zimbabwe approves the emergency use of the Janssen COVID-19 vaccine made by Johnson & Johnson after they previously denied approval, making it the first Western-made vaccine to be approved for use in the country.
2021-07-28

The Johnson & Johnson vaccine will resume rollouts in Europe.
2021-04-20

White House COVID-19 Response Coordinator Jeff Zients says that the Biden administration will accelerate doses of the Pfizer-BioNTech and Moderna vaccines. The move comes after the United States suspended usage of the Johnson & Johnson vaccine.
2021-04-14

The United States suspends the use of the Johnson & Johnson vaccine following concerns of blood clots.
2021-04-13

California Governor Gavin Newsom receives the Johnson & Johnson vaccine.
2021-04-1

Johnson & Johnson's single-shot COVID-19 vaccine candidate meets the standards for emergency use authorization, according to analysis from a committee within the FDA, though formal authorization will not be determined until February 26. The vaccine is 66% effective in combating the virus and can be stored in normal refrigerators.
2021-02-24

South African pharmaceutical company Aspen Pharmacare announces that they have made a deal with Johnson & Johnson to manufacture their COVID-19 vaccine candidate if approved in South Africa and internationally.
2020-11-2

AstraZeneca and Johnson & Johnson resume their Phase III trials in the United States for a COVID-19 vaccine after previously pausing them as a result of complications with some volunteers.
2020-10-23

Indonesia aims to start administering COVID-19 vaccines early next month, according to the Coordinating Ministry for Maritime and Investment Affairs. Sinopharm and G42 Healthcare will supply five million doses starting next month, CanSino Biologics will supply 100,000 doses that same time, and Sinovac will supply three million doses of CoronaVac by December. All three vaccines are currently in Phase III trials in various countries.
2020-10-12